Literature DB >> 6615729

Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II).

W J Mawby, M J Tanner, D J Anstee, J R Clamp.   

Abstract

The alterations in the erythrocyte membrane proteins of individuals with congenital dyserythropoietic anaemia (CDA II) were studied. Alterations were observed in both the erythrocyte sialoglycoproteins and erythrocyte anion transport protein (Band 3). There was a decrease in the apparent molecular weight of the major sialoglycoprotein alpha (glycophorin A) as well as a general reduction in the intensity of staining of all the sialoglycoproteins by the PAS stain. Sialoglycoprotein alpha isolated from CDA II erythrocytes contained 30% less sialic acid than normal alpha. The anion transport protein of CDA II erythrocytes migrated as a band with a lower molecular weight than the normal protein on SDS-gel electrophoresis. The CDA II anion transport protein had a substantially reduced content of N-acetylglucosamine and galactose, which probably reflects a reduction in the number of N-acetyl-lactosamine units carried by the protein. Our results suggest that there is a general defect in glycosylation of the major membrane glycoproteins of CDA II erythrocytes. We suggest that this glycosylation defect is a consequence of bone marrow stress.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615729     DOI: 10.1111/j.1365-2141.1983.tb01257.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.

Authors:  M N Fukuda; K A Masri; A Dell; L Luzzatto; K W Moremen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic series.

Authors:  C Vermylen; J M Scheiff; J Rodhain; J Ninane; G Cornu
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

Review 3.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

4.  Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.

Authors:  Timothy J Satchwell; Stephanie Pellegrin; Paola Bianchi; Bethan R Hawley; Alexandra Gampel; Kathryn E Mordue; Annika Budnik; Elisa Fermo; Wilma Barcellini; David J Stephens; Emile van den Akker; Ashley M Toye
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

Review 5.  The COPII pathway and hematologic disease.

Authors:  Rami Khoriaty; Matthew P Vasievich; David Ginsburg
Journal:  Blood       Date:  2012-05-14       Impact factor: 22.113

6.  SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells.

Authors:  Barbara Eleni Rosato; Roberta Marra; Vanessa D'Onofrio; Federica Del Giudice; Simone Della Monica; Achille Iolascon; Immacolata Andolfo; Roberta Russo
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

Review 7.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.